Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
作者信息
Forastiere A A, Crain S M, Callahan K, Van Echo D, Mattox D, Thant M, Von Hoff D D, Wiernik P H
出版信息
Cancer Treat Rep. 1982 Dec;66(12):2097-8.
PMID:6892491
Abstract
摘要
相似文献
1
Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.氮丙啶基苯醌（AZQ）用于头颈癌的II期试验。
Cancer Treat Rep. 1982 Dec;66(12):2097-8.
2
Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).癌症与白血病B组二期非小细胞肺癌试验：氮丙啶基苯醌（AZQ）。
Cancer Treat Rep. 1983 Jan;67(1):95-6.
3
Aziridinylbenzoquinone (AZQ) in advanced breast cancer: a Cancer and Leukemia group B phase II trial.氮丙啶基苯醌（AZQ）用于晚期乳腺癌：癌症与白血病B组II期试验
Cancer Treat Rep. 1982 Oct;66(10):1875-6.
4
Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
Cancer Treat Rep. 1982 Dec;66(12):2089-90.
5
Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
Cancer Treat Rep. 1983 May;67(5):507-8.
6
Phase II evaluation of diaziquone in recurrent head and neck cancer.
Cancer Treat Rep. 1986 May;70(5):671-2.
7
Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Cancer Treat Rep. 1982 Jun;66(6):1321-5.
8
Preliminary communication--treatment of primary brain tumors recurrent after irradiation with aziridinylbenzoquinone (AZQ;NSC-182986).
Am J Clin Oncol. 1983 Oct;6(5):577-8.
9
Phase I study of aziridinylbenzoquinone (NSC 182986).氮丙啶基苯醌（NSC 182986）的I期研究。
Cancer Clin Trials. 1981 Winter;4(4):459-63.
10
Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
Cancer Res. 1982 Apr;42(4):1582-6.
Zotero 插件